Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,108
archived clinical trials in
Lupus

A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
326
mi
from
Allentown, TX
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
326
mi
from
Allentown, TX
Click here to add this to my saved trials
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
515
mi
from
Austin, TX
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
515
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
340
mi
from
Dallas, TX
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
340
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
572
mi
from
Houston, TX
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
572
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
588
mi
from
Nassau Bay, TX
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
588
mi
from
Nassau Bay, TX
Click here to add this to my saved trials
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
1121
mi
from
Arlington, VA
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1121
mi
from
Arlington, VA
Click here to add this to my saved trials
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
1411
mi
from
Seattle, WA
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1411
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
632
mi
from
Milwaukee, WI
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
632
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
1182
mi
from
Pennsylvania, WY
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1182
mi
from
Pennsylvania, WY
Click here to add this to my saved trials
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
5602
mi
from
Ciudad Autonoma de Buenos Aires,
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
5602
mi
from
Ciudad Autonoma de Buenos Aires,
Click here to add this to my saved trials
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
1306
mi
from
Fort Lauderdale, FL
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1306
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
852
mi
from
Saint Clair Shores, MI
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
852
mi
from
Saint Clair Shores, MI
Click here to add this to my saved trials
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
415
mi
from
Saint Louis, MO
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
415
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
737
mi
from
Mobile, AL
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
737
mi
from
Mobile, AL
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
848
mi
from
Tempe, AZ
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
848
mi
from
Tempe, AZ
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1142
mi
from
La Jolla, CA
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1142
mi
from
La Jolla, CA
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1162
mi
from
La Palma, CA
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1162
mi
from
La Palma, CA
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1179
mi
from
Los Angeles, CA
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1179
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1179
mi
from
Los Angeles, CA
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1179
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1324
mi
from
San Leandro, CA
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1324
mi
from
San Leandro, CA
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1176
mi
from
Torrance, CA
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1176
mi
from
Torrance, CA
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1320
mi
from
Miami, FL
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1320
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1148
mi
from
Baltimore, MD
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1148
mi
from
Baltimore, MD
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
810
mi
from
Ann Arbor, MI
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
810
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1288
mi
from
Brooklyn, NY
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1288
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1296
mi
from
Flushing, NY
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1296
mi
from
Flushing, NY
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1301
mi
from
Great Neck, NY
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1301
mi
from
Great Neck, NY
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1302
mi
from
Manhasset, NY
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1302
mi
from
Manhasset, NY
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1290
mi
from
New York, NY
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1290
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1290
mi
from
New York, NY
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1290
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1043
mi
from
Chapel Hill, NC
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1043
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1066
mi
from
Raleigh, NC
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1066
mi
from
Raleigh, NC
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
815
mi
from
Columbus, OH
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
815
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1209
mi
from
Bethlehem, PA
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1209
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1223
mi
from
Philadelphia, PA
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1223
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1223
mi
from
Philadelphia, PA
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1223
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1063
mi
from
Charleston, SC
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1063
mi
from
Charleston, SC
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
326
mi
from
Allentown, TX
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
326
mi
from
Allentown, TX
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
515
mi
from
Austin, TX
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
515
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
340
mi
from
Dallas, TX
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
340
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1112
mi
from
Fairfax, VA
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1112
mi
from
Fairfax, VA
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1236
mi
from
Kennewick, WA
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1236
mi
from
Kennewick, WA
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
545
mi
from
Onalaska, WI
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
545
mi
from
Onalaska, WI
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
5602
mi
from
Ciudad Autonoma Buenos Aires,
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
5602
mi
from
Ciudad Autonoma Buenos Aires,
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1132
mi
from
Ocoee, FL
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1132
mi
from
Ocoee, FL
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
1049
mi
from
Gainesville, FL
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1049
mi
from
Gainesville, FL
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
415
mi
from
Saint Louis, MO
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
415
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 4, Multi-Center, Randomized, Open-Label Study to Evaluate the Effect of BENLYSTA™ (Belimumab; HGS1006) on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
676
mi
from
Birmingham, AL
A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 4, Multi-Center, Randomized, Open-Label Study to Evaluate the Effect of BENLYSTA™ (Belimumab; HGS1006) on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
676
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 4, Multi-Center, Randomized, Open-Label Study to Evaluate the Effect of BENLYSTA™ (Belimumab; HGS1006) on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
843
mi
from
Paradise Valley, AZ
A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 4, Multi-Center, Randomized, Open-Label Study to Evaluate the Effect of BENLYSTA™ (Belimumab; HGS1006) on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
843
mi
from
Paradise Valley, AZ
Click here to add this to my saved trials
A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 4, Multi-Center, Randomized, Open-Label Study to Evaluate the Effect of BENLYSTA™ (Belimumab; HGS1006) on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
429
mi
from
Shreveport, LA
A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 4, Multi-Center, Randomized, Open-Label Study to Evaluate the Effect of BENLYSTA™ (Belimumab; HGS1006) on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
429
mi
from
Shreveport, LA
Click here to add this to my saved trials